Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026
Q2 2026
Est. EPS: $10.36
Actual EPS: $9.47
EPS surprise: 6.24%
Company overview
Market Cap$70.9B
PriceUSD 676.69
P/E16.49
EPS (TTM)41.04
52-week high821.11
52-week low541.00
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410